Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight […]
Apr 11, 2025
Can we support fill finish?
Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight and documentation.
Latest News
eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies
Dec 2, 2025
Industry News
eXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway
Nov 26, 2025
Industry News
eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading CGT services in Southeast Asia
Sep 23, 2025
Industry News
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.